Message #12 From:
NewsBot Date: March 28, 2007 05:30:00 AM
IFMX News InforMedix and excelleRx Team to Ensure Consumer Adherence with Prescribed Medications
ROCKVILLE, Md.--(BUSINESS WIRE)--InforMedix Holdings, Inc. (OTCBB: IFMX), developer of a portable, interactive “smart pillbox” caregiver system that helps the chronically ill manage their medications and diseases, has signed an agreement with excelleRx to ensure that patients properly manage their medications. excelleRx, a division of Omnicare (NYSE: OCR), provides medication monitoring, consulting, and pharmaceutical distribution services to over 240,000 hospice patients, as well as health plans and disease management organizations.
Under the terms of the agreement, excelleRx will market and sell InforMedix’s Med-eMonitor patient interactive system to select customers. The system consists of a small portable digital device, a medication storage compartment, an LCD screen, keypad, and a telephone jack connection. At scheduled intervals, patients are instructed by the device to take their prescribed medicine, and then asked to confirm whether they have taken their medications. They are also provided with medication and disease-specific educational information, and report information regarding their physical and mental health status.
InforMedix will adopt excelleRx’s medication management support services, including pharmaceutical consultation, medication risk management, and information distribution service. Services provided by an excelleRx pharmacy professional will include patient enrollment, monitoring and counseling, as well as immediate notification about a patient’s condition to clinicians and family members in support of InforMedix’s consumer product launch.
“Joining our two services will enable us to launch our Med-eMonitor system through retail channel partners,” said Bruce A. Kehr, M.D., Chairman and Chief Executive Officer of InforMedix. “We will now be able to provide a full ‘end-to-end solution’ for both the disease management market and all those consumers who need our help the most.”
Participants enrolled in a medication management program, such as Medicare Part D, or those provided by a union fund, pharmacy, or managed care organization, are eligible to use the Med-eMonitor system.
“The elderly and those with chronic conditions often have complex medication regimens that make them particularly vulnerable to medication-related problems,” said Calvin H. Knowlton, R.Ph., M.Div., Ph.D., Chairman and Chief Executive Officer of excelleRx. “We are pleased topartner with InforMedix in using the latest technology to ensure the appropriate use of medication.”
On March 5,2007, ADT Security Services, a unit of Tyco Fire & Security, XLHealth, one of the nation’s fastest growing disease management companies, and InforMedix, a provider of medication and care plan compliance devices, announced they are working together to address medication adherence issues among a targeted group of participants in Tennessee’s Medicare Health Support program.
According to the October 2006 issue of Psychiatric Times, one in six (or an estimated 50 million) Americans is on three or more medications per day. Patients with chronic conditions and the elderly take more prescription drugs and have more prescribing physicians than the general population. Whenever the chronically ill do not take their medications, it can often lead to serious complications, even death. Recently, a number of Fortune 500 companies have been investing in the home health monitoring industry.
“Our goal is to use technology to reduce healthcare costs nationwide and improve the quality of life through remote patient medication and care plan monitoring,” said Dr. Kehr. “We are deeply committed to providing the reassurance that a loved one’s caregiver needs every day.”
About InforMedix
InforMedix, based in Rockville, MD, has developed the Med-eMonitor System as The Medication Adherence Solution for disease management and retail products markets. InforMedix has integrated a portable patient-interactive monitoring device, hardware, software and networked communications system to enable disease management programs, chronically ill patients and their loved ones, and medical researchers to efficiently monitor and manage patients' medication and care plan adherence, clinical response, and drug safety. To find out more about InforMedix, Inc., (OTCBB:IFMX), visit the Company website at www.informedix.com.
About ExcelleRx
Established in 1996, excelleRx provides medication counseling and pharmaceutical distribution services for hospice and chronic care patients throughout the United States. By combining proprietary technology and clinical expertise, excelleRx ensures optimal and cost appropriate use of medication, and thereby enhances the quality of life. Headquartered in Philadelphia, excelleRx has operations in Memphis, Tempe, AZ, and Sharon Hill, PA. For more information, visit the excelleRx web site at www.excelleRx.com.
Safe Harbor Statement
This press release may contain forward looking statements that involve risks and uncertainties, including statements regarding our business strategy and development plans, plans for entering into new businesses, anticipated sources and uses of funds and other statements regarding our plans, objectives, expectations and intentions that are not historical facts. Because these forward-looking statements involve risks and uncertainties, actual results could differ materially from those discussed in this press release. These risks and uncertainties are described in greater detail in the reports that we file with the Securities and Exchange Commission. Our actual results, performance or achievements may vary materially from those expressed or implied in any forward-looking statements. All forward-looking statements reflect our beliefs and expectations as of the date of this press release and should not be relied upon as representing our views as of any subsequent date. While we may elect to update these forward-looking statements publicly at some point in the future, we specifically disclaim any obligation to do so, whether as a result of new information, future events or otherwise.
